Jules Bordet Institute
124
25
33
46
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
16.1%
20 terminated/withdrawn out of 124 trials
69.7%
-16.8% vs industry average
6%
8 trials in Phase 3/4
7%
3 of 46 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (124)
HER2 Molecular Imaging With 89Zr-trastuzumab PET/CT as a Predictive Biomarker for Antibody-drug Conjugate Sequencing in Patients With Advanced HER2-positive Breast Cancer
Role: lead
A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients
Role: lead
Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer
Role: lead
SCALp Cooling for pReventing aLopecia With nEw anTibody-drug Conjugates
Role: lead
Integrating Peritoneal Histological Growth Patterns Into Preoperative Decision-Making for Colorectal Peritoneal Metastses
Role: lead
Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy.
Role: lead
Flash Radiotherapy for Skin Cancer
Role: lead
Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.
Role: lead
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Role: collaborator
Prophylactic Intervention for Dysgeusia in Head and Neck Cancer Patients Following Radio(Chemo)Therapy
Role: lead
Testosterone Supplementation in Patients in Best Supportive Care: Impact on Quality of Life
Role: lead
Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study (Oligopro-Breast)
Role: lead
LUtetium-177 DOsimetry as a Predictive Biomarker of Response in Metastatic Prostate Cancer Patients Treated With PSMA Radioligand THerapy.
Role: lead
Parental Support Intervention in an Advanced Oncological Context
Role: collaborator
A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid Tumours
Role: lead
Antibody-based PET Imaging and Treatment Response in Breast Cancer Treated With an Antibody-drug Conjugate.
Role: collaborator
Efficacy and Safety of Conventional Neoadjuvant Therapy Versus Total Neoadjuvant Therapy in Older Patients With Locally Advanced Rectal Cancer
Role: lead
e-Motion : Promoting Emotion Regulation in Chronic Cancer
Role: collaborator
Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
Role: collaborator
Molecular Imaging of Cancer-associated Fibroblasts in Glioblastoma: a FAPI PET/MR Study.
Role: lead